1087659-24-2 Usage
Description
5-Bromo-3-methoxypicolinaldehyde is an organic compound characterized by its unique molecular structure, which features a bromo and methoxy group attached to a picolinaldehyde backbone. 5-Bromo-3-methoxypicolinaldehyde is known for its potential applications in the pharmaceutical industry due to its versatile chemical properties.
Uses
Used in Pharmaceutical Synthesis:
5-Bromo-3-methoxypicolinaldehyde is used as a building block for the synthesis of various pharmaceuticals. Its unique structure allows it to be a valuable component in the development of new drugs, particularly those targeting specific medical conditions.
In the pharmaceutical industry, 5-Bromo-3-methoxypicolinaldehyde is used as a key intermediate in the development of novel therapeutic agents. Its chemical properties make it suitable for the creation of molecules with potential applications in treating a range of diseases and disorders. The compound's versatility in synthesis contributes to its importance in the ongoing search for innovative and effective medications.
Check Digit Verification of cas no
The CAS Registry Mumber 1087659-24-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,8,7,6,5 and 9 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1087659-24:
(9*1)+(8*0)+(7*8)+(6*7)+(5*6)+(4*5)+(3*9)+(2*2)+(1*4)=192
192 % 10 = 2
So 1087659-24-2 is a valid CAS Registry Number.
1087659-24-2Relevant articles and documents
N-(2-(4-((1R,3R)-3-METHYL-2,3,4,9-TETRAHYDRO-1H-PYRIDO[3,4-B]INDOL-1-YL)PHENOXY)ETHYL)PROPAN-1-AMINE DERIVATIVES AND RELATED COMPOUNDS AS SELECTIVE DOWN-REGULATORS OF THE ESTROGEN RECEPTOR FOR TREATING CANCER
-
, (2018/02/28)
The specification relates to compounds of Formula (I) and to pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, pharmaceutical compositions containing them and to the compounds of Formula (I) for use as selective down-regulators of the estrogen receptor in the treatment of cell proliferative disorders, such as cancer.
